Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advaxis Inc.
Advaxis' Dr. John Rothman to Present at the Bio International Convention in San Diego, CA
July 11th, 2008
Dr. John Rothman CEO of Advaxis Inc., (OTCBB: ADXS), a developmental biotechnology company, is scheduled to present at the BIO International Convention (BIO) today, Wednesday, June 18, 2008, at 1:00PM PDT in the GEN Theater. Dr. Rothman's presentation, entitled "The Use Of Bioengineered Listeria Monocytogenes As A Live Cancer Vaccine," will detail how modified live Listeria bacteria is being used as the vector to target cervical and prostate cancer. The world's largest gathering of the biotechnology industry, BIO is a symposium that features leading pharmaceutical and biotechnology companies presenting emerging sector trends to institutional investors, portfolio...
Source: Health Business Week (2008-07-11)
|
